RECRUITING

Hepatitis C Tracker Study

Description

The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing unsheltered homelessness and receiving street medicine. Research will compare medication adherence among participants randomly assigned to receive standard medical care for Hepatitis C versus the standard medical care for Hepatitis C along with GPS tracking assistance.

Study Overview

Study Details

Study overview

The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing unsheltered homelessness and receiving street medicine. Research will compare medication adherence among participants randomly assigned to receive standard medical care for Hepatitis C versus the standard medical care for Hepatitis C along with GPS tracking assistance.

Effects of GPS Tracking on Patient Adherence to Hepatitis C Treatment Among People Experiencing Unsheltered Homelessness

Hepatitis C Tracker Study

Condition
Hepatitis C Virus Infection
Intervention / Treatment

-

Contacts and Locations

Alhambra

USC Street Medicine, Alhambra, California, United States, 91803

Ventura

Ventura County Medical Center, Ventura, California, United States, 93003

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosed with Hepatitis C infection
  • * Experiencing unsheltered homelessness at study initiation
  • * Speaks English or Spanish
  • * Receiving street medicine care
  • * Meet the American Association for the Study of Liver Diseases (AASLD) criteria for simplified treatment of Hepatitis C
  • * Prior engagement in HCV treatment
  • * Decompensated cirrhosis; HBsAg positive
  • * Current pregnancy; Known or suspended hepatocellular carcinoma
  • * Prior liver transplantation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Southern California,

Camilo Zaks, MD, PRINCIPAL_INVESTIGATOR, University of Southern California, Keck School of Medicine of USC, Department of Family Medicine, USC Street Medicine

Tipu Kahn, MD, PRINCIPAL_INVESTIGATOR, Ventura County Medical Center

Study Record Dates

2027-12-31